Citation Impact
Citing Papers
Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase
2007 StandoutNobel
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Comparison of Confirmatory Tests for the Diagnosis of Primary Aldosteronism
2006
Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots
2003
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism
2012
Independent β-Arrestin2 and Gq/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor
2009 StandoutNobel
β-Arrestin Scaffolding of the ERK Cascade Enhances Cytosolic ERK Activity but Inhibits ERK-mediated Transcription following Angiotensin AT1a Receptor Stimulation
2002 StandoutNobel
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Enhanced Aldosterone Signaling in the Early Nephropathy of Rats with Metabolic Syndrome
2006
Primary aldosteronism
2011
Autophagy and the Integrated Stress Response
2010 Standout
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Laboratory challenges in primary aldosteronism screening and diagnosis
2015
Enhancement of specificity of aldosterone measurement in human serum and plasma using 2D-LC–MS/MS and comparison with commercial immunoassays
2014
The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms
2012
Plasma Aldosterone Is Related to Severity of Obstructive Sleep Apnea in Subjects With Resistant Hypertension
2007
Angiotensin II increases adipose angiotensinogen expression
2007
Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans
2010
Using PAC nested deletions to order contigs and microsatellite markers at the high repetitive sequence containing Npr3 gene locus
2001 StandoutNobel
The metabolic syndrome
2010 Standout
Confirmatory Testing in Primary Aldosteronism
2012
Cushing's syndrome
2015 Standout
β-Arrestin 1 and Gαq/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor Stimulation
2004 StandoutNobel
Bioactive Natural Constituents from Food Sources—Potential Use in Hypertension Prevention and Treatment
2013
Association Studies between Microsatellite Markers within the Gene Encoding Human 11β-Hydroxysteroid Dehydrogenase Type 1 and Body Mass Index, Waist to Hip Ratio, and Glucocorticoid Metabolism
2002
Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates
2011
Adrenalectomy Improves Arterial Stiffness in Primary Aldosteronism
2008
The sympathetic nervous system in white adipose tissue regulation
2001
Local adipose tissue renin-angiotensin system
2008
Pros and cons of screening for occult Cushing syndrome
2011
Systemic and renal growth hormone–IGF1 axis involvement in a mouse model of type 2 diabetes
2007
DNA methylation in metabolic disorders
2011
18-Oxocortisol Measurement in Adrenal Vein Sampling as a Biomarker for Subclassifying Primary Aldosteronism
2011
Confirmatory testing in primary aldosteronism: extensive medication switching is not needed in all patients
2012
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Expression of Angiotensin Type-1 (AT1) and Type-2 (AT2) Receptor mRNAs in the Adult Rat Brain: A Functional Neuroanatomical Review
1997
Adrenalectomy Is Comparable With Medical Treatment for Reduction of Left Ventricular Mass in Primary Aldosteronism: Meta-Analysis of Long-Term Studies
2014
Primary aldosteronism: renaissance of a syndrome
2007
Adipokines in inflammation and metabolic disease
2011 Standout
AMPK, insulin resistance, and the metabolic syndrome
2013
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Ren1c Homozygous Null Mice Are Hypotensive and Polyuric, but Heterozygotes Are Indistinguishable from Wild-Type
2004 StandoutNobel
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Reduced Expression of Insulin Receptors in the Kidneys of Insulin-Resistant Rats
2007
Type 2 diabetes
2017 Standout
11β-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory
2004
Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates
2012 Standout
Stress and the brain: from adaptation to disease
2005 Standout
Chronic cold exposure results in subcutaneous adipose tissue browning and altered global metabolism in Qinghai-Tibetan plateau pika (Ochotona curzoniae)
2018 StandoutNobel
Insulin resistance and the metabolic syndrome
2005
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
A Novel Form of Human Mendelian Hypertension Featuring Nonglucocorticoid-Remediable Aldosteronism
2008
Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases
2004
Sudden cardiac death and obesity
2014
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Obesity cardiomyopathy: pathogenesis and pathophysiology
2007
The Role of Aldosterone in the Metabolic Syndrome
2011
Cushing's syndrome
2006 Standout
The effect of RAAS blockade on the progression of diabetic nephropathy
2013
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
2016 StandoutNature
Aldosterone and end-organ damage
2005
Metformin—mode of action and clinical implications for diabetes and cancer
2014
Attenuation of Diet-Induced Weight Gain and Adiposity through Increased Energy Expenditure in Mice Lacking Angiotensin II Type 1a Receptor
2005
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
2014
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
2009
11β-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension
2004
Adipose Tissue as an Endocrine Organ
2004 Standout
The adipose-tissue renin–angiotensin–aldosterone system: role in the metabolic syndrome?
2003
Adrenal vein sampling: Substantial need for technical improvement at regional referral centres
2013
Diagnosis and Treatment of Primary Aldosteronism
2011
Seated Saline Suppression Testing For The Diagnosis Of Primary Aldosteronism: A Preliminary Study
2014
A Clinical Prediction Score to Diagnose Unilateral Primary Aldosteronism
2012
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism
2008
Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II–Induced Hypertension
1999
Adiponectin Deficiency, Diastolic Dysfunction, and Diastolic Heart Failure
2009
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Weight Loss and the Renin-Angiotensin-Aldosterone System
2005
Possible involvement of the adipose tissue renin‐angiotensin system in the pathophysiology of obesity and obesity‐related disorders
2003
Predictors of Decreasing Glomerular Filtration Rate and Prevalence of Chronic Kidney Disease After Treatment of Primary Aldosteronism: Renal Outcome of 213 Cases
2013
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
AMPK and SIRT1: a long-standing partnership?
2010
Novel Fat Depot–Specific Mechanisms Underlie Resistance to Visceral Obesity and Inflammation in 11β-Hydroxysteroid Dehydrogenase Type 1–Deficient Mice
2011
Waist Girth Does Not Predict Metabolic Complications in Severely Obese Men
2006
Impact of Waist Circumference on the Relationship Between Blood Pressure and Insulin
2005
Diabetic Cardiomyopathy
2018 Standout
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
Prolonged Zona Glomerulosa Insufficiency Causing Hyperkalemia in Primary Aldosteronism after Adrenalectomy
2012
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
2000 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
An Expert Consensus Statement on Use of Adrenal Vein Sampling for the Subtyping of Primary Aldosteronism
2013
Left Ventricular Structure and Function in Obese Adolescents: Relations to Cardiovascular Fitness, Percent Body Fat, and Visceral Adiposity, and Effects of Physical Training
2002
Thyroid Hormone Regulation of Metabolism
2014 Standout
Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system
2002
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation
2011
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
An Increased Circulating Angiotensin II Concentration is Associated with Hypoadiponectinemia and Postprandial Hyperglycemia in Men with Nonalcoholic Fatty Liver Disease
2013
Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling
2005 StandoutNobel
Stress Hormone Regulation: Biological Role and Translation into Therapy
2009
Pathophysiology of Sleep Apnea
2010 Standout
Mechanisms of Diabetic Complications
2013 Standout
Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy With Treatment of Primary Aldosteronism
2013
Differential actions of renal ischemic injury on the intrarenal angiotensin system
2000
Vascular Remodeling and Duration of Hypertension Predict Outcome of Adrenalectomy in Primary Aldosteronism Patients
2008
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Measurement of Peripheral Plasma 18-Oxocortisol Can Discriminate Unilateral Adenoma From Bilateral Diseases in Patients With Primary Aldosteronism
2015
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
2007 Standout
Automated Chemiluminescence-Immunoassay for Aldosterone during Dynamic Testing: Comparison to Radioimmunoassays with and without Extraction Steps
2006
Intrarenal Hemodynamics in Primary Aldosteronism before and after Treatment
2009
Age Below 40 or a Recently Proposed Clinical Prediction Score Cannot Bypass Adrenal Venous Sampling in Primary Aldosteronism
2014
Aldosterone and end-organ damage
2007
Rapid Cortisol Assay during Adrenal Vein Sampling in Patients with Primary Aldosteronism
2007
Ectopic and Abnormal Hormone Receptors in Adrenal Cushing’s Syndrome*
2001
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Gilberta Giacchetti being referenced
A Common Polymorphism in the Mineralocorticoid Receptor Modulates Stress Responsiveness
2006
Overexpression of the Renin-Angiotensin System in Human Visceral Adipose Tissue in Normal and Overweight Subjects
2002
Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol
2006
Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects
2002
Ontogenic Expression of Renal and Hepatic Angiotensin II Receptor Genes in the Rat
1997
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats
2003
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis
2008
Metabolic syndrome in primary aldosteronism and essential hypertension: Relationship to adiponectin gene variants
2009
Proceedings of the Symposium ‘Angiotensin AT1Receptors: From Molecular Physiology to Therapeutics’: ANGIOTENSIN II AND THE ADRENAL
1996
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma
2007
The tissue renin-angiotensin system in rats with fructose- induced hypertension
2000
The renin–angiotensin–aldosterone system, glucose metabolism and diabetes
2005
Primary aldosteronism and essential hypertension: Assessment of cardiovascular risk at diagnosis and after treatment
2013
Gene expression of angiotensinogen in adipose tissue of obese patients
2000
Diagnosis of primary aldosteronism: from screening to subtype differentiation
2005
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study
2006
Obesity and hypertension
2000
Decreased expression of insulin-sensitive glucose transporter mRNA (GLUT-4) in adipose tissue of non-insulin-dependent diabetic and obese patients: Evaluation by a simplified quantitative PCR assay
1994
Adipose cell–adrenal interactions: current knowledge and future perspectives
2008
Primary aldosteronism: cardiovascular, renal and metabolic implications
2008
Tissue-Specific Regulation of Type 1 Angiotensin II Receptor mRNA Levels in the Rat
1996
Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism
2012
Changes in Adenosine 5′-Monophosphate-Activated Protein Kinase as a Mechanism of Visceral Obesity in Cushing’s Syndrome
2008
CA-Repeat Polymorphism in Intron 1 of HSD11B2
2000
Polymorphisms ofEDNRB,ATG, andACEgenes in salt-sensitive hypertensionThis article is one of a selection of papers published in the special issue (part 2 of 2) on Forefronts in Endothelin.
2008
Comparison of the Captopril and the Saline Infusion Test for Excluding Aldosterone-Producing Adenoma
2007
Analysis of Insulin Sensitivity in Adipose Tissue of Patients with Primary Aldosteronism
2010
Late-Onset Apparent Mineralocorticoid Excess Caused by Novel Compound Heterozygous Mutations in the HSD11B2 Gene
2003
Within-Patient Reproducibility of the Aldosterone:Renin Ratio in Primary Aldosteronism
2009
AMP‐activated protein kinase mediates glucocorticoid‐ induced metabolic changes: a novel mechanism in Cushing's syndrome
2008
Renal Damage in Primary Aldosteronism
2006
Comparison of the Captopril and the Saline Infusion Test for Excluding Aldosterone-Producing Adenoma
2007
Body Mass Index Predicts Plasma Aldosterone Concentrations in Overweight-Obese Primary Hypertensive Patients
2008